 FARMINGDALE, N.Y., Sept. 02, 2021 GLOBE NEWSWIRE -- Misonix, Inc. Nasdaq: MSON Misonix or the Company, a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported unaudited financial results for the fiscal 2021 fourth quarter and full fiscal year ended June 30, 2021 as summarized below: 